Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults.

Ariceta G, Lara E, Camacho JA, Oppenheimer F, Vara J, Santos F, Muñoz MA, Cantarell C, Gil Calvo M, Romero R, Valenciano B, García-Nieto V, Sanahuja MJ, Crespo J, Justa ML, Urisarri A, Bedoya R, Bueno A, Daza A, Bravo J, Llamas F, Jiménez Del Cerro LA.

Nephrol Dial Transplant. 2015 Mar;30(3):475-80. doi: 10.1093/ndt/gfu329.

2.

Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Nesterova G, Williams C, Bernardini I, Gahl WA.

Pediatr Nephrol. 2015 Jun;30(6):945-51. doi: 10.1007/s00467-014-3018-x.

PMID:
25526929
3.

Mood and illness experiences of adults with cystinosis.

Beinart N, Hackett RA, Graham CD, Weinman J, Ostermann M.

Ren Fail. 2015 Jun;37(5):835-9. doi: 10.3109/0886022X.2015.1015391.

PMID:
25715639
4.

Recent advances in the treatment of cystinosis.

Schneider JA, Clark KF, Greene AA, Reisch JS, Markello TC, Gahl WA, Thoene JG, Noonan PK, Berry KA.

J Inherit Metab Dis. 1995;18(4):387-97. Review.

5.

Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate.

Besouw M, Tangerman A, Cornelissen E, Rioux P, Levtchenko E.

Mol Genet Metab. 2012 Sep;107(1-2):234-6. doi: 10.1016/j.ymgme.2012.06.017.

PMID:
22832073
6.

[Intra-leukocyte cystine in cystinosis treated with cysteamine].

Ged C, Jean G, Tete MJ, Broyer M, Kamoun P.

Ann Biol Clin (Paris). 1991;49(9):482-6. French.

PMID:
1789502
7.

A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.

Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1112-20. doi: 10.2215/CJN.12321211. Erratum in: Clin J Am Soc Nephrol. 2013 Mar 7;8(3):468.

8.

[Cystinosis in adults: A systemic disease].

Servais A, Goizet C, Bertholet-Thomas A, Decramer S, Llanas B, Choukroun G, Novo R.

Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Review. French.

PMID:
25769364
9.

Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.

Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P, Servais A.

Kidney Int. 2012 Jan;81(2):179-89. doi: 10.1038/ki.2011.277.

10.

N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis.

Pache de Faria Guimaraes L, Seguro AC, Shimizu MH, Lopes Neri LA, Sumita NM, de Bragança AC, Aparecido Volpini R, Cunha Sanches TR, Macaferri da Fonseca FA, Moreira Filho CA, Vaisbich MH.

Pediatr Nephrol. 2014 Jun;29(6):1097-102. doi: 10.1007/s00467-013-2705-3.

PMID:
24326786
11.

Nephropathic cystinosis in children: An overlooked disease.

Soliman NA, El-Baroudy R, Rizk A, Bazaraa H, Younan A.

Saudi J Kidney Dis Transpl. 2009 May;20(3):436-42.

12.

[Treatment of cystinosis using cysteamine].

Broyer M, Tete MJ.

Ann Pediatr (Paris). 1990 Feb;37(2):91-3. French.

PMID:
2321906
13.

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.

Bouazza N, Tréluyer JM, Ottolenghi C, Urien S, Deschenes G, Ricquier D, Niaudet P, Chadefaux-Vekemans B.

Orphanet J Rare Dis. 2011 Dec 23;6:86. doi: 10.1186/1750-1172-6-86.

14.

[Peculiarity of infantile cystinosis in Tunisian children].

Jellouli M, Ben Turkia H, Abidi K, Hammi Y, Gargah T.

Pan Afr Med J. 2015 Dec 11;22:348. doi: 10.11604/pamj.2015.22.348.7727. French. No abstract available.

15.

Long-term treatment of cystinosis in children with twice-daily cysteamine.

Dohil R, Gangoiti JA, Cabrera BL, Fidler M, Schneider JA, Barshop BA.

J Pediatr. 2010 May;156(5):823-7. doi: 10.1016/j.jpeds.2009.11.059.

PMID:
20138296
16.

Pharmacological treatment of nephropathic cystinosis with cysteamine.

Kleta R, Gahl WA.

Expert Opin Pharmacother. 2004 Nov;5(11):2255-62. Review.

PMID:
15500372
17.

Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.

Berryhill A, Bhamre S, Chaudhuri A, Concepcion W, Grimm PC.

Pediatr Transplant. 2016 Feb;20(1):141-5. doi: 10.1111/petr.12617.

PMID:
26477696
18.

Parenchymal organ cystine depletion with long-term cysteamine therapy.

Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC.

Biochem Med Metab Biol. 1992 Dec;48(3):275-85.

PMID:
1476793
19.

Improved renal function in children with cystinosis treated with cysteamine.

Markello TC, Bernardini IM, Gahl WA.

N Engl J Med. 1993 Apr 22;328(16):1157-62.

20.

Follow-up and treatment of adults with cystinosis in the Netherlands.

Geelen JM, Monnens LA, Levtchenko EN.

Nephrol Dial Transplant. 2002 Oct;17(10):1766-70.

Items per page

Supplemental Content

Support Center